Integrative Therapeutics
Cyto-Redoxin
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
3
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category B
- Green TeaCategory B
LiverTox Category B (for concentrated extracts only, not brewed tea). High-dose EGCG (>800 mg/day) from supplements linked to hepatotoxicity. EFSA 2018 opinion. USP verification recommended.
LiverTox →
Supplement Facts
11 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Total Carbohydrates CarbohydrateUNII · 0 | 1 g | 1% |
| Vitamin A UNII · 81G40H8B0T | 10000 IU | 200% |
| Vitamin C UNII · PQ6CK8PD0R | 500 mg | 833% |
| Vitamin E UNII · H4N855PNZ1 | 100 IU | 333% |
| Zinc UNII · J41CSQ7QDS | 7.5 mg | 50% |
| Selenium UNII · H6241UJ22B | 100 mcg | 143% |
| AnthoRedoxin(TM) Proprietary Blend (Herb/Botanical) | 500 mg | — |
| NAC N-Acetyl Cysteine | 150 mg | — |
| Alpha Lipoic Acid UNII · 73Y7P0K73Y | 50 mg | — |
| Green Tea (Camellia sinensis) leaf extract Green TeaUNII · W2ZU1RY8B0 | 40 mg | — |
| natural Coenzyme Q10 Coenzyme Q-10 | 25 mg | — |
FDA CAERS · adverse event context
3
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · Ascorbyl Palmitate · Cellulose · Soybean Oil